Acura OTC Stock Buy Hold or Sell Recommendation


USD 0.01  0.00  0.00%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Acura Pharma Cmn is 'Strong Sell'. Macroaxis provides Acura Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ACUR positions. The advice algorithm takes into account all of Acura Pharma's available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Acura Pharma's buy-and-hold perspective. Please continue to Acura Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Acura and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Acura Pharma Cmn.

Execute Acura Pharma Buy or Sell Advice

The Acura recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acura Pharma Cmn. Macroaxis does not own or have any residual interests in Acura Pharma Cmn or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acura Pharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Acura PharmaBuy Acura Pharma
Strong Sell



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Reporting Quality (M-Score)

For the selected time horizon Acura Pharma Cmn has a Mean Deviation of 8.57, Standard Deviation of 19.97 and Variance of 398.87
We provide trade advice to complement the prevailing expert consensus on Acura Pharma Cmn. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Acura Pharma is not overpriced, please confirm all Acura Pharma Cmn fundamentals, including its revenue, short ratio, z score, as well as the relationship between the total debt and total asset . As Acura Pharma Cmn appears to be a penny stock we also recommend to validate its number of shares shorted numbers.

Acura Pharma Trading Alerts and Improvement Suggestions

Acura Pharma Cmn generated a negative expected return over the last 90 days
Acura Pharma Cmn has high historical volatility and very poor performance
Acura Pharma Cmn has some characteristics of a very speculative penny stock
Acura Pharma Cmn has a very high chance of going through financial distress in the upcoming years
The company currently holds 324 K in liabilities with Debt to Equity (D/E) ratio of 2.4, implying the company greatly relies on financing operations through barrowing. Acura Pharma Cmn has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Acura Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Acura Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Acura Pharma Cmn sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Acura to invest in growth at high rates of return. When we think about Acura Pharma's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 2.25 M. Net Loss for the year was (1.15 M) with profit before overhead, payroll, taxes, and interest of 1.79 M.
Acura Pharma Cmn currently holds about 89 K in cash with (396 K) of positive cash flow from operations.
Roughly 19.0% of Acura Pharma shares are held by company insiders

Acura Pharma Returns Distribution Density

The distribution of Acura Pharma's historical returns is an attempt to chart the uncertainty of Acura Pharma's future price movements. The chart of the probability distribution of Acura Pharma stock daily returns describes the distribution of returns around its average expected value. We use Acura Pharma Cmn price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acura Pharma returns is essential to provide solid investment advice for Acura Pharma.
Mean Return-2.62Value At Risk-40.48
Potential Upside8.70Standard Deviation19.97
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acura Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Acura Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Acura Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acura Pharma Cmn backward and forwards among themselves. Acura Pharma's institutional investor refers to the entity that pools money to purchase Acura Pharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Captrust Financial AdvisorsCommon Shares2450.0
Lenox Wealth Advisors LlcCommon Shares7800.0
Captrust Financial AdvisorsCommon Shares2450.0
Lenox Wealth Advisors LlcCommon Shares7800.0
Captrust Financial AdvisorsCommon Shares2450.0
Lenox Wealth Advisors LlcCommon Shares7800.0
Lenox Wealth Advisors LlcCommon Shares7801000
Note, although Acura Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Acura Pharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Acura Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Acura Pharma's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Acura otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW-1.85
Overall volatility
Information ratio -0.13

Acura Pharma Volatility Alert

Acura Pharma Cmn is displaying above-average volatility over the selected time horizon. Investors should scrutinize Acura Pharma Cmn independently to ensure intended market timing strategies are aligned with expectations about Acura Pharma volatility. Acura Pharma Cmn is a penny stock. Although Acura Pharma may be in fact a good investment, many penny otc stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Acura Pharma Cmn. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Acura instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Acura Pharma Fundamentals Vs Peers

Comparing Acura Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Acura Pharma's direct or indirect competition across all of the common fundamentals between Acura Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Acura Pharma or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Acura Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Acura Pharma by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Acura Pharma to competition
FundamentalsAcura PharmaPeer Average
Return On Equity0.85 %(0.31) %
Return On Asset(38.42) %(0.14) %
Profit Margin(51.27) %(1.27) %
Operating Margin(49.35) %(5.51) %
Current Valuation7.39 M16.62 B
Shares Outstanding65.09 M571.82 M
Shares Owned by Insiders18.66 %10.09 %
Shares Owned by Institutions3.01 %39.21 %
Number of Shares Shorted89.85 K4.71 M
Price to Earning125.00 X28.72 X
Price to Book35.00 X9.51 X
Price to Sales0.29 X11.42 X
Revenue2.25 M9.43 B
Gross Profit1.79 M27.38 B
EBITDA(1.03 M)3.9 B
Net Income(1.15 M)570.98 M
Cash and Equivalents89 K2.7 B
Total Debt324 K5.32 B
Debt to Equity2.40 %48.70 %
Current Ratio0.86 X2.16 X
Book Value Per Share(0.27) X1.93 K
Cash Flow from Operations(396 K)971.22 M
Short Ratio0.73 X4.00 X
Earnings Per Share(0.04) X3.12 X
Number of Employees1218.84 K
Market Capitalization650.89 K19.03 B
Total Asset16.96 M29.47 B
Retained Earnings(418.63 M)9.33 B
Working Capital10.89 M1.48 B
Current Asset14.13 M9.34 B
Current Liabilities3.24 M7.9 B
Z Score-32.48.72
   Exercise or conversion by Albert Brzeczko of 34000 shares of Acura Pharma subject to Rule 16b-3 [view details]

Acura Pharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acura . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Acura Pharma Buy or Sell Advice

When is the right time to buy or sell Acura Pharma Cmn? Buying financial instruments such as Acura OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Acura Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Convertibles Thematic Idea Now

Convertibles Theme
Funds or Etfs that invest in debt that is expected to be converted into a predetermined amount of the company equity at some future date. The Convertibles theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Convertibles Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Acura Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for analysis

When running Acura Pharma Cmn price analysis, check to measure Acura Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acura Pharma is operating at the current time. Most of Acura Pharma's value examination focuses on studying past and present price action to predict the probability of Acura Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acura Pharma's price. Additionally, you may evaluate how the addition of Acura Pharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Acura Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acura Pharma. If investors know Acura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acura Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Acura Pharma Cmn is measured differently than its book value, which is the value of Acura that is recorded on the company's balance sheet. Investors also form their own opinion of Acura Pharma's value that differs from its market value or its book value, called intrinsic value, which is Acura Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acura Pharma's market value can be influenced by many factors that don't directly affect Acura Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acura Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Acura Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acura Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.